News

Results 1 - 10 of 890

  • Doctor performing surgery with a team

    Sk8 to Elimin8 Cancer™ Detroit Celebration and Ice Show was another fantastic event this year, bringing out more spectators and raising more money amidst beautiful weather. Though the ice had to be kept cold, viewers enjoyed 50-degree weather under the colorful lights at the Campus Martius Park ice rink. The atmosphere was perfect to enjoy amazing performances and celebrate cancer research through the Scott Hamilton CARES Foundation and the Barbara Ann Karmanos Cancer Institute . “Detroit is home to som...

  • Doctor performing surgery with a team

    Paul Poole never expected his life would change in the blink of an eye. At 69 years old, he was enjoying his life in Redford with his wife of 32 years, Carol, and playing rounds of golf on his local course. But in May 2022, that’s exactly what happened. It all started with a seizure. Poole was driving home from his brother’s house when his wife noticed he was acting strange. “I kept looking out of the sideview mirror as I was driving. I was shaking my head, jerking it, and my wife kept thinking somethin...

  • Doctor performing surgery with a team

    A team of researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) were awarded a $1.4 million, three-year grant from the U.S. Department of Defense for the study, “Cytochrome c acetylation drives prostate cancer aggressiveness and Warburg effect.” The study, led by Maik Hüttemann, Ph.D., Tumor Biology and Microenvironment (TBM) Research Program member at Karmanos, professor of Molecular Medicine and Genetics, and Biochemistry, Microbiology and Immunology at WSU’s School...

  • Doctor performing surgery with a team

    The ASCO Post A new four-drug therapy called Smart Stop was presented at the 2023 American Society of Hematology (ASH) Annual Meeting & Exposition. Investigators reported this targeted therapy is promising for first-line treatment of diffuse large B-cell lymphoma (DLBCL). Dipenkumar Modi, M.D. , hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, reviewed the study and agrees that Smart Stop could ...

  • Doctor performing surgery with a team

    WILX Daniel Isaac, D.O., MS , hematologist and medical oncologist, member of the Breast Cancer and Genitourinary Oncology Multidisciplinary Teams (MDT) at Karmanos, joins Studio 10. He explains the collaborative relationship physicians at Karmanos Cancer Institue at McLaren Greater Lansing have with their MDT members at the headquarters in Detroit, the significance of the partnership with MSU Health Care, and the specializations of each oncologist at the Lansing location. Watch the interview here .

  • Doctor performing surgery with a team

    Voravit Ratanatharathorn, M.D., is a well-respected physician here at the Barbara Ann Karmanos Cancer Institute, a world-renowned hematologist, medical oncologist and BMT clinical scientist. Throughout the years, Dr. Voravit changed the standard of care for blood, bone marrow, and stem cell transplants and co-authored revolutionary studies while caring for his patients. He plans to retire at the end of February 2024. Dr. Voravit received his Bachelor of Science degree in Medical Science at Mahidol Unive...

  • Doctor performing surgery with a team

    Prostate Cancer Aware Isaac Powell, M.D. , urologic oncologist, member of the  Genitourinary Oncology Multidisciplinary Team  and the  Population Studies and Disparities Research Program  at Karmanos, explains his research of identifying genes and other risk factors that cause more advanced prostate cancer diagnoses among African American men than European men. He also addresses why there is mistrust in the health care system among African Americans.

  • Doctor performing surgery with a team

    In 2018 Bob Floria applied for life insurance.  He had to have a physical before the insurance company would approve him.  Because his prostate-specific antigen (PSA) test results showed something suspicious, the insurer would not cover him.  Bob did not follow up on the PSA results until four years later.   “I was really tired. I wasn’t functioning at my normal level. I have sleep apnea and AFib, so I thought it might be that at first,” Bob said. “But I was also going to the ba...

  • Doctor performing surgery with a team

    In just over five years since opening, the McLaren Proton Therapy Center in Flint, part of the Karmanos Cancer Network, has demonstrated its ability to deliver care proficiently and effectively by reaching the milestone of treating its 1,000th cancer patient. Treating its first patient in late 2018, the Center, one of only two in the state, celebrated the completion of its 1,000th patient’s treatment — a mid-Michigan woman receiving care for recurring breast cancer — in January 2024. And as the McLaren ...

  • Doctor performing surgery with a team

    A recently published study led by researchers at the Barbara Ann Karmanos Cancer Institute investigates the molecular mechanism of action of Selinexor in pancreatic ductal adenocarcinoma and the tumor’s surrounding microenvironment. Asfar Azmi, Ph.D., Molecular Therapeutics (MT) Research Program Leader and Pancreas Cancer Research Director at Karmanos, guided this study titled “ Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model ,” publis...